Follow
Arminder K Deol
Arminder K Deol
Verified email at lshtm.ac.uk
Title
Cited by
Cited by
Year
Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study
A Clark, M Jit, C Warren-Gash, B Guthrie, HHX Wang, SW Mercer, ...
The Lancet Global Health 8 (8), e1003-e1017, 2020
10602020
Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study
AJ Kucharski, P Klepac, AJK Conlan, SM Kissler, ML Tang, H Fry, JR Gog, ...
The Lancet infectious diseases 20 (10), 1151-1160, 2020
9972020
Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study
NG Davies, AJ Kucharski, RM Eggo, A Gimma, WJ Edmunds, T Jombart, ...
The Lancet Public Health 5 (7), e375-e385, 2020
8502020
Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
K Abbas, SR Procter, K van Zandvoort, A Clark, S Funk, T Mengistu, ...
The Lancet Global Health 8 (10), e1264-e1272, 2020
3662020
Schistosomiasis—assessing progress toward the 2020 and 2025 global goals
AK Deol, FM Fleming, B Calvo-Urbano, M Walker, V Bucumi, I Gnandou, ...
New England Journal of Medicine 381 (26), 2519-2528, 2019
1762019
An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary …
KME Turner, J Round, P Horner, J Macleod, S Goldenberg, A Deol, ...
Sexually transmitted infections 90 (2), 104-111, 2014
892014
Population genetic structure of Schistosoma mansoni and Schistosoma haematobium from across six sub-Saharan African countries: implications for epidemiology, evolution and control
CM Gower, AN Gouvras, PHL Lamberton, A Deol, J Shrivastava, ...
Acta tropica 128 (2), 261-274, 2013
822013
Evaluating the variation in the projected benefit of community-wide mass treatment for schistosomiasis: Implications for future economic evaluations
HC Turner, JE Truscott, AA Bettis, SH Farrell, AK Deol, JM Whitton, ...
Parasites & vectors 10, 1-15, 2017
422017
The cost and cost-effectiveness of novel tuberculosis vaccines in low-and middle-income countries: A modeling study
A Portnoy, RA Clark, M Quaife, CK Weerasuriya, C Mukandavire, ...
PLoS medicine 20 (1), e1004155, 2023
182023
Associations between infection intensity categories and morbidity prevalence in school-age children are much stronger for Schistosoma haematobium than for S. mansoni
RE Wiegand, WE Secor, FM Fleming, MD French, CH King, AK Deol, ...
PLoS neglected tropical diseases 15 (5), e0009444, 2021
182021
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
RA Clark, C Mukandavire, A Portnoy, CK Weerasuriya, A Deol, ...
The Lancet Global Health 11 (4), e546-e555, 2023
172023
Urogenital schistosomiasis in Cabo Delgado, northern Mozambique: baseline findings from the SCORE study
AE Phillips, PH Gazzinelli-Guimarães, HO Aurelio, N Dhanani, J Ferro, ...
Parasites & vectors 11, 1-10, 2018
172018
Estimating ventilation rates in rooms with varying occupancy levels: Relevance for reducing transmission risk of airborne pathogens
AK Deol, D Scarponi, P Beckwith, TA Yates, AS Karat, AWC Yan, ...
PloS one 16 (6), e0253096, 2021
122021
Modelling the effect of infection prevention and control measures on rate of Mycobacterium tuberculosis transmission to clinic attendees in primary health clinics in South Africa
N McCreesh, AS Karat, K Baisley, K Diaconu, F Bozzani, I Govender, ...
BMJ global health 6 (10), e007124, 2021
102021
Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in …
A Deol, JP Webster, M Walker, MG Basáñez, TD Hollingsworth, ...
Parasites & vectors 9, 1-15, 2016
82016
Markov model predicts changes in STH prevalence during control activities even with a reduced amount of baseline information
A Montresor, A Deol, N à Porta, N Lethanh, D Jankovic
PLoS neglected tropical diseases 10 (4), e0004371, 2016
8*2016
Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need
N Cherian, A Bettis, A Deol, A Kumar, JL Di Fabio, A Chaudhari, S Yimer, ...
npj Vaccines 8 (1), 123, 2023
62023
Demonstrating multi-country calibration of a tuberculosis model using new history matching and emulation package-hmer
D Scarponi, A Iskauskas, RA Clark, I Vernon, TJ McKinley, M Goldstein, ...
Epidemics 43, 100678, 2023
62023
Direct estimates of absolute ventilation and estimated Mycobacterium tuberculosis transmission risk in clinics in South Africa
PG Beckwith, AS Karat, I Govender, AK Deol, N McCreesh, K Kielmann, ...
PLOS Global Public Health 2 (11), e0000603, 2022
22022
Importance of ventilation and occupancy to Mycobacterium tuberculosis transmission rates in congregate settings
AK Deol, N Shaikh, K Middelkoop, M Mohlamonyane, RG White, ...
BMC public health 22 (1), 1772, 2022
22022
The system can't perform the operation now. Try again later.
Articles 1–20